Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Imein Bousnina

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Therapeutic Innovation & Regulatory Science|May 4, 2025
Has FDA's Drug Development Tools Qualification Program Improved Drug Development?Felix Yang, Imein Bousnina, Anne Madej, et al.
Clinical Pharmacology and Therapeutics|July 1, 2023
Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical PharmacologyBenjamin Ribba, Richard Peck, Lucy Hutchinson, et al.
NPJ Digital Medicine|August 10, 2023
Incorporating digitally derived endpoints within clinical development programs by leveraging prior workAmy Bertha, Rinol Alaj, Imein Bousnina, et al.
Drug Discovery Today|March 14, 2025
Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessmentJacintha Shenton, Imein Bousnina, Michael Oropallo, et al.
Nature Reviews. Drug Discovery|March 6, 2025
Accelerating adoption of new approach methodologies in regulatory decision making: an industry perspectiveAndrew S Robertson, Nahid Latif, Imein Bousnina, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Therapeutic Innovation & Regulatory Science|May 4, 2025
Has FDA's Drug Development Tools Qualification Program Improved Drug Development?Felix Yang, Imein Bousnina, Anne Madej, et al.
Clinical Pharmacology and Therapeutics|July 1, 2023
Digital Therapeutics as a New Therapeutic Modality: A Review from the Perspective of Clinical PharmacologyBenjamin Ribba, Richard Peck, Lucy Hutchinson, et al.
NPJ Digital Medicine|August 10, 2023
Incorporating digitally derived endpoints within clinical development programs by leveraging prior workAmy Bertha, Rinol Alaj, Imein Bousnina, et al.
Drug Discovery Today|March 14, 2025
Opportunities and insights from pharmaceutical companies on the current use of new approach methodologies in nonclinical safety assessmentJacintha Shenton, Imein Bousnina, Michael Oropallo, et al.
Nature Reviews. Drug Discovery|March 6, 2025
Accelerating adoption of new approach methodologies in regulatory decision making: an industry perspectiveAndrew S Robertson, Nahid Latif, Imein Bousnina, et al.
Pageof 1